Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo.

Am J Hematol 2011 Oct 2;86(10):897-902. Epub 2011 Aug 2.

Department of Hematology Oncology, University of Pavia, Fondazione Policlinico San Matteo, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Pavia.

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.22104
Publisher Site
http://dx.doi.org/10.1002/ajh.22104DOI Listing
October 2011
19 Reads

Publication Analysis

Top Keywords

iron chelation
8
report working
4
working conference
4
transplantation report
4
treated allogeneic
4
stem-cell transplantation
4
conference iron
4
chelation gruppo
4
midollo osseo
4
trapianto midollo
4
italiano trapianto
4
gruppo italiano
4
syndrome treated
4
allogeneic stem-cell
4
patients myelodysplastic
4
overload iron
4
chelation therapy
4
myelodysplastic syndrome
4
iron overload
4
therapy patients
4

References

(Supplied by CrossRef)
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
Malcovati et al.
Haematologica 2006
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age
Deeg et al.
Blood 2000
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia
Sierra et al.
Blood 2002
Stem cell transplantation for patients with myelodysplastic syndrome and secondary leukemias
De Witte et al.
Int J Hematol 2000

Similar Publications